The Contribution of A. I. in Pharmaceutical Software


Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2025 | Volume : 03 | Issue : 01 | Page : –
    By

    Mohd. Wasiullah,

  • Piyush Yadav,

  • Vikash Yadav,

  1. Principal, Department of Pharmacy, Prasad Institute Technology, Jaunpur, Uttar Pradesh, India
  2. Academic Head, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
  3. Lecturer, Department of Pharmacy, Prasad institute of technology, Jaunpur, Uttar Pradesh, India

Abstract

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_174899’);});Edit Abstract & Keyword

The integration of Artificial Intelligence (AI) in pharmaceutical software has significantly transformed drug development, regulatory processes, and clinical management. AI-powered tools are revolutionizing data analysis, predictive modeling, and decision-making, enhancing the efficiency and accuracy of drug discovery and development. This article explores the multifaceted contributions of AI to pharmaceutical software, including its applications in drug screening, personalized medicine, clinical trial optimization, and regulatory compliance. Additionally, we examine how AI is improving the management of patient data, optimizing supply chain processes, and supporting the development of new therapeutic solutions. The article delves into the challenges and ethical dilemmas of integrating AI into the pharmaceutical industry, stressing the importance of transparent practices, safeguarding data privacy, and ensuring thorough validation. This review seeks to present a snapshot of AI’s current role and future prospects in pharmaceutical software, shedding light on how these innovations are transforming healthcare and medicine.

Keywords: Computer system software, GMP practices, regulatory agency requirements, product quality, healthcare and medicine

[This article belongs to International Journal of Biomedical Innovations and Engineering (ijbie)]

How to cite this article:
Mohd. Wasiullah, Piyush Yadav, Vikash Yadav. The Contribution of A. I. in Pharmaceutical Software. International Journal of Biomedical Innovations and Engineering. 2025; 03(01):-.
How to cite this URL:
Mohd. Wasiullah, Piyush Yadav, Vikash Yadav. The Contribution of A. I. in Pharmaceutical Software. International Journal of Biomedical Innovations and Engineering. 2025; 03(01):-. Available from: https://journals.stmjournals.com/ijbie/article=2025/view=0


document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_174899’);});Edit

References

  1. Chakraborty C, Sonawane KD, Jain G, Banerjee S. Artificial intelligence in drug development and discovery. Pharm Res. 2020;37(10):196.
  2. Joubert SI, Delalonde M, Heghinian K, Al-Shehri M, Zinger S, et al. The impact of artificial intelligence in drug discovery: A comprehensive review. J Pharm Sci. 2022;111(7):1814-1832.
  3. Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8-17.
  4. Schwaber JS, Searle SR. AI and machine learning in drug development: The path to revolutionizing healthcare. Pharm Innov. 2019;14(3):12-17.
  5. Vamathevan J, Clark D, Czodrowski P, Dunham I, et al. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019;18(6):463-477.
  6. Wang F, Kesselheim AS, Franklin JM, Ross KM, et al. Artificial intelligence in pharmaceutical research and development. Adv Drug Deliv Rev. 2021;170:3-19.
  7. Silver D, Huang A, Maddison CJ, Guez A, Sifre L, et al. Mastering the game of Go with deep neural networks and tree search. Nature. 2016;529(7587):484-489.
  8. Huang S, Yang J, Fong S, Zhao Q. Artificial intelligence for drug discovery and development: A review of current applications. J Clin Pharmacol. 2020;60(7):922-937.
  9. Liu X, Faes L, Kale AU, Wagner SK, et al. AI-driven drug discovery: The state of the art. Drug Discov Today. 2020;25(8):1405-1415.
  10. Zhou Y, Yeung W, Wang Y, Zhang S. Artificial intelligence in pharmacovigilance: Current applications and future directions. Pharmacol Res. 2022;180:106195.
  11. Rodrigues T, Bernardes GJ, Lam K, Orgogozo A, et al. Machine learning in pharmaceutical research and drug development. Eur J Med Chem. 2019;163:48-60.
  12. Bender A, Cortes-Ciriano I, Chen H, et al. Applications of artificial intelligence in drug discovery: A review. J Med Chem. 2018;61(22):9631-9641.
  13. Vidal D, Pastor M, Baqué P, et al. Artificial intelligence in drug discovery: A systematic review and future perspectives. J Transl Med. 2020;18(1):1-12.
  14. Ekins S, Puhl AC, Zorn KM, Lane TR, et al. The role of artificial intelligence in drug discovery and development. Expert Opin Drug Discov. 2019;14(10):1215-1226.
  15. Vamathevan J, Clark D, Czodrowski P, Dunham I, et al. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019;18(6):463-477.
  16. Chen H, Engkvist O, Wang Y, Olivecrona M, Blaschke T. The rise of deep learning in drug discovery. Drug Discov Today. 2018;23(6):1241-1251.
  17. Sliwoski G, Kothiwale S, Meiler J, Lowe EW. Computational methods in drug discovery and development. Pharmacol Rev. 2014;66(1):18-48.
  18. Kaiser D, Rodriguez JA, Schuler J, Fetz V, et al. AI for precision medicine in the pharmaceutical industry: A review. Comput Biol Chem. 2020; 85:107224.
  19. Ramsundama R, Owens DR, Dagum P. Massively parallel methods for drug discovery. J Chem Inf Model. 2017;57(10):2194.
  20. Zhou Y, Wang Y, Zhang S, Du X. Artificial intelligence in drug discovery and development: A critical review of the status. J Pharm Innov. 2021; 26:75-88.
  21. Ochoa D, Shah D, Besnard J, et al. Applications of machine learning in drug development: A focus on the discovery process. Expert Opin Drug Discov. 2019;14(9):965-975.
  22. Rosenblatt M, Kimmelman J, Lemke J, Friberg L. Artificial intelligence in clinical trials: Applications and potential benefits. Pharm Med. 2020;34(5):329-337.
  23. Garcia S, Verhoeven D, Sharma T, et al. Applications of artificial intelligence in the pharmacogenomics of drug response. Hum Genomics. 2021;15(1):9.
  24. Kermani BG, Brocchini S, Penketh PG, et al. AI for drug repositioning: An overview of methods and applications. Pharmacol Ther. 2022; 227:1078.
Regular Issue Subscription Review Article
Volume 03
Issue 01
Received 14/12/2024
Accepted 29/12/2024
Published 21/02/2025
Publication Time 69 Days
117

async function fetchCitationCount(doi) {
let apiUrl = `https://api.crossref.org/works/${doi}`;
try {
let response = await fetch(apiUrl);
let data = await response.json();
let citationCount = data.message[“is-referenced-by-count”];
document.getElementById(“citation-count”).innerText = `Citations: ${citationCount}`;
} catch (error) {
console.error(“Error fetching citation count:”, error);
document.getElementById(“citation-count”).innerText = “Citations: Data unavailable”;
}
}
fetchCitationCount(“10.37591/IJBIE.v03i01.0”);

Loading citations…